Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Cingulate Inc. (CING)

4.8850 -0.3250 (-6.24%)
As of 10:05:44 AM EDT. Market Open.
Chart Range Bar
Loading chart for CING
  • Previous Close 5.2100
  • Open 5.0000
  • Bid 3.5700 x 200
  • Ask 6.3100 x 200
  • Day's Range 4.8500 - 5.0800
  • 52 Week Range 3.1600 - 11.8900
  • Volume 85,797
  • Avg. Volume 453,232
  • Market Cap (intraday) 65.796M
  • Beta (5Y Monthly) -0.91
  • PE Ratio (TTM) --
  • EPS (TTM) -4.3300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 23.00

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

www.cingulate.com

14

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 8/13/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CING
12.56%
S&P 500 (^GSPC)
14.02%

1-Year Return

CING
32.74%
S&P 500 (^GSPC)
20.71%

3-Year Return

CING
96.30%
S&P 500 (^GSPC)
74.85%

5-Year Return

CING
99.59%
S&P 500 (^GSPC)
74.70%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue --
Earnings -9.31M

Q3

FY25

Q4

FY25

Q1

FY26

-8M
-6M
-4M
-2M
0

Analyst Insights

View More

Analyst Price Targets

8.00
23.00 Average
4.8850 Current
52.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 6/8/2026
Analyst Ascendiant Capital
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 55 -> 52

Statistics

View More

Valuation Measures

Annual
As of 8/10/2026
  • Market Cap

    70.71M

  • Enterprise Value

    52.25M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    3.76

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -69.68%

  • Return on Equity (ttm)

    -225.11%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -27.91M

  • Diluted EPS (ttm)

    -4.3300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    25.89M

  • Total Debt/Equity (mrq)

    39.38%

  • Levered Free Cash Flow (ttm)

    -11.92M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

4.8850 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Insider Picks for 02/22/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 02/21/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 02/17/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 02/16/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: